← Open Payments lookup

MELISSA NOYES: Open Payments

NPI 1801244074 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,140 in 36 payments from 19 companies in 2025. Trend: 2023 $165 · 2024 $1,407 · 2025 $1,140

Food & beverage: $1,040Education: $100
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$198
Incyte Corporation3$163
GlaxoSmithKline, LLC.2$139
SEAGEN INC.1$100
Janssen Biotech, Inc.3$75
Genmab U.S., Inc.2$68
Takeda Pharmaceuticals U.S.A., Inc.2$46
Ipsen Biopharmaceuticals, Inc2$45
Merck Sharp & Dohme LLC2$41
GENZYME CORPORATION1$37

Products named: Niktimvo, ZEJULA, Tivdak, IMFINZI, LYNPARZA, Onivyde, KEYTRUDA, JAKAFI.

Industry payments across AZ — which companies pay providers there.